Tarsus Pharmaceuticals Q3 Loss Narrows, Revenue Surges-February 2024-www.financetom.com

Tarsus Pharmaceuticals Q3 Loss Narrows, Revenue Surges

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Tarsus Pharmaceuticals Q3 Loss Narrows, Revenue Surges

Nov 13, 2024 2:02 PM

04:35 PM EST, 11/13/2024 (MT Newswires) -- Tarsus Pharmaceuticals ( TARS ) reported a Q3 loss late Wednesday of $0.61 per diluted share, compared with a $1.28 loss a year earlier.

Analysts polled by Capital IQ expected a loss of $0.92.

Revenue for the quarter that ended Sept. 30 was $48.1 million, up from $1.87 million a year earlier.

Analysts surveyed by Capital IQ expected $43.2 million.

Previous page： MarketAxess Holdings Founder, Executive Chairman Rick McVey to Retire Next page： Cellebrite DI Chief Executive Yossi Carmil to Step Down

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

MarketAxess Holdings Founder, Executive Chairman Rick McVey to Retire

Nov 9, 2024

09:10 AM EST, 11/06/2024 (MT Newswires) -- MarketAxess Holdings ( MKTX ) said Wednesday that its founder and executive chairman, Rick McVey, will retire at the end of the year. MarketAxess ( MKTX ) said McVey will remain board chairman of the company's international holding unit. Carlos Hernandez, the current chair of the board's compensation and talent committee, will succeed...

Cellebrite DI Chief Executive Yossi Carmil to Step Down

Nov 9, 2024

09:10 AM EST, 11/06/2024 (MT Newswires) -- Cellebrite DI ( CLBT ) said Wednesday that Chief Executive Yossi Carmil will step down by Dec. 31. The company said it has named Executive Chairman Thomas E. Hogan as interim CEO until a new CEO is found. Shares of the company were up 5% in recent premarket activity. Price: 20.10, Change: +0.95,...

Sunoco Q3 Earnings: Revenue Drop, Stronger Cash Flow & More

Nov 9, 2024

Sunoco LP ( SUN ) shares are trading lower after it reported third-quarter revenues of $5.75 billion, which missed the consensus of $6.508 billion. Adjusted distributable cash flow of $349 million was higher than $181 million a year ago. Adjusted EBITDA increased to $456 million from $257 million a year ago. The Fuel Distribution segment sold around 2.1 billion gallons of fuel (+1% year over year), with the fuel margin for...

Nov 9, 2024

...